COMPARISON OF RISPERIDONE WITH OLANZAPINE FOR TREATMENT OF IRANIAN PATIENTS WITH SCHIZOPHRENIA: A TRIPLE BLIND, RANDOMIZED CLINICAL TRIAL (2020)
About Publisher
Editorial Policies
Peer Review Policy
Editorial & Peer Review Process
Author's Rights and Obligations
Publication Ethics and Publication Malpractice Statement
Conflict of Interest Policy
Plagiarism Policy
Protection of Research Participants (Statement On Human And Animal Rights)
Privacy Policy
Corrections, Retractions & Expressions of Concern
Self-Archiving Policies
Statement of Informed Consent
Advertising Policy
License Information
|
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Journal of Critical Reviews are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
|
|
|
|
Copyright � 2021 Journal of Critical Reviews All Rights Reserved. Subject to change without notice from or liability to Journal of Critical Reviews. For best results, please use Internet Explorer or Google Chrome |
Contact InformationJournal of Critical Review,
|